One thing for sure...the market did not respond positively in any way to Don's presentation. I guess there is no surprise there. Every time Don presents it drives the share price down!

There is a huge gap between the share price and what I believe the net present value should be for a phase 111 trial drug and today's update did not help at all. It would seem that Don has no credibility what-so-ever and that the new VP of Investor Relations has had not impact to date. I wonder if he will end up like Cherrington?

Oh well, just another disappointing day with this stock. I'm not expecting anything positive on the share price soon, particularly if performances like today continue.

GLTA

Toinv